Appears to enhance weightloss and glucose effects when combined with GLP1, based on dualagonist data (such as tirzepatide). Glucagon receptor activation Increases energy expenditure and promotes fat oxidation when balanced properly with GLP1 and GIP. May help reduce liver fat and visceral (deep abdominal) fat, which are strongly linked to cardiometabolic risk. By combining these three pathways, retatrutide aims to reduce appetite, improve metabolic control, and increase calorie burning more strongly than current single or dualagonist drugs
It is widely distributed in the body, with the highest concentrations found in the liver, kidneys, and lungs
Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM anti-CD3) as a targeted cancer immunotherapy
It has been shown that peripheral blood monocytes in AIDS patients are low in intracellular L-carnitine [21]
Four made our shortlist under named clinical leads
Liu A, Cai Y, Yuan Y, Liu M, Zhang Z, Xu Y, Jiao P